Reported Jun 12, 2024 · Terminated
Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60…
GlaxoSmithKline LLC
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: GlaxoSmithKline LLC · 1011 N Arendell Ave · Zebulon, NC · 27597-2309
Is this the product you have?
- Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only
- Mfd forViiV Healthcare Durham, NC, 27701
- By
GlaxoSmithKline DurhamNC 27701NDC 49702-255-37
- Lot codes and dates
Lot #: AG4MLabeled Expiry date on carton May 2026correct Exp. Date 04/2025
- Amount recalled
- 463 Cartons
Where it was sold
- Nationwide
Why it was recalled
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new GlaxoSmithKline LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.